1. Stimulation of oxidative metabolism of granulocytes by recombinant human GM-CSF and a conditioned medium of a Urinary Bladder Carcinoma cell line
M. Klausmann, K.H. Pflüger, D. Krumwieh, F.R. Seiler, K. Havemann
Blut 1987;54:307-312
 
2. Stimulation des oxidativen Stoffwechsels von Granulozyten durch rH.GM-CSF und konditioniertes Medium der Blasenkarzinomzellinie 5637.
M. Klausmann, K.H. Pflüger, F.R. Seiler, K. Havemann
Klin. Wochenschr 1987;65:190
 
3. Modulation of functions of granulocytes by human GM-CSF and possible complications of GM-CSF therapy.
M. Klausmann, K.H. Pflüger, D. Krumwieh, F.R. Seiler, K. Havemann
Leukemia 1988;2(12): S63-S72
 
4. Influence of recombinant human granulocyte-macrophage colony stimulating factor on granulocyte functions.
M. Klausmann, K.H. Pflüger, D. Krumwieh, F.R. Seiler, K. Havemann
Behring Inst. Mitt. 1988; 83: 265-269
 
5. Granulocyte-macrophage colony-stimulating factor binding sites and oxidative metabolism in human granulocytes.
M. Häder, M. Klausmann, K.H. Pflüger, G. Lüben, F.R. Seiler K. Havemann
Blut 1989; 59:486-492
 
6. Blood erythroid progenitors (CFU.E and BFU.E) in acute lymphoblastic leukemia.
V. Praloran, M. Klausmann, M.F. Naud, J.L. Harousseau
Blut 1989;58:75-78
 
7. Collagen gel cultures for detection of spared hematopoietic progenitors in Asta Z 7557 purged bone marrow.
V. Praloran, I. Dobo, R. Garand, M. Klausmann, M.F. Naud, N. Milpied, J.L. Harousseau
Leukemia 1990;4:282-286
 
8. Effects of recombinant human interleukin-3 in aplastic anemia.
A. Ganser, A. Lindemann, G. Seipelt, O. Ottmann, M. Eder, S. Falk, F. Hermann, J.P. Kaltwasser, P. Meusers, M. Klausmann, J. Frisch, G. Schulz, R. Mertelsmann, d. Hoelzer.
Blood 1990;76(7):1287-1292
 
9.Effects of recombinant human Interleukin-3 in patients with myelodysplastic syndromes.
A. Ganser, G. Seipelt, A. Lindemann, O.G. Ottman, S. Falk, M. Eder, F, Hermann, R. Becher, K. Höffken, T. Büchner, M. Klausmann, J. Frisch, G. Schulz, R. Mertelsmann D. Hoelzer
Blood 1990;76(3):455-462
 
10. Effect of rH.GM-CSF on hematopoietic reconstitution after chemotherapy in small cell lung cancer.
K. Havemann, M. Klausmann, M. Wolf, J.R. Fischer, P. Drings, W. Oster
J Cancer Res Clin Oncol 1991,117:S203-S207
 
11. GM-CSF versus G-CSF in the treatment of infectious complication in Felty´s syndrome-a case report.
U. Kaiser, M. Klausmann, G. Richter, K.H. Pflüger
Ann Hematol 1992;64:205-206
 
12. Felty´s syndrome: favorable response to GM-CSF in the acute phase.
U. Kaiser, M. Klausmann, G. Kolb, K.H. Pflüger, K. Havemann
Acta Haematol 1992;87:190-194
 
13. High-Dose Cyclophosphamide, Etoposide and BCNU with non-cryopreserved Autologous Bone Marrow Transplantation for Poor Prognosis Malignant Lymphoma
H. Koeppler, K.H. Pflüger, M. Klausmann, K. Havemann
Leukemia and Lymphoma 1992;6:219-222
 
14. Granulocyte-Monocyte Colony-stimulating factor levels during hemodialysis-induced leukopenia.
G. Kolb, M. Klausmann, I. Eckle, T. Müller, H. Lange, K. Havemann
Nephron 1993;65:466-468
 
15.GM-CSF in the treatment of small cell lung cancer
M. Wolf, M. Klausmann, K. Havemann
Sem Onc 1994 ; 5 (21):51-56
 
16. Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b.
R. Weide, K. Ehlenz, W. Lorenz, E. Walthers, M. Klausmann, K.H. Pflüger
Ann. Hematol. 1996; 72:41-43
 
17. Effect of treatment with amifostin used as a single agent in patients with refractory anemia on clinical outcome and serum TNF alpha levels.
W.K. Hofmann, G. Seipelt, O.G. Ottmann, U. Kalina, S. Koschmieder, J. Brücher, N. Frickhofen, M. Klausmann, P.S. Mitrou, D. Hoelzer
submitted for publication in „annals of hematology”
 

Buchbeiträge
 
1. Colony-stimulating factors in solid tumors: paraneoplastic production and growth -modulating activity.
M. Klausmann, K.H. Pflüger, K. Havemann
Hematopoietic Growth Factors in Clinical Applications, edited by R. Mertelsmann and F. Hermann, Marcel Dekker, inc. 1991: Chap. 26:421-430
 

Vorträge (Als Abstract publiziert)
 
1. Stimulation of oxidative metabolism of granulocytes by recombinant human GM-CSF and a conditioned medium of a Urinary Bladder Carcinoma cell line
M. Klausmann, K.H. Pflüger, D. Krumwieh, F.R. Seiler, K. Havemann
Blut 1987;54:307-312
32nd Annual Meeting of the German Society of Hematology and Oncology,Tübingen 1986
 
2. Effect of rH. GM-CSF on hematopoietic reconstitution after chemotherapy in small cell lung cancer.
M. Wolf, M. Klausmann, J.R. Fischer, P. Drings, K. Havemann
Abstract second international conference on small cell lung cancer, Ravenna Italy , May11-12,1990.
 
3. Influence of the schedule of GM-CSF application on chemotherapy-induced myelosuppression.
M. Klausmann, M. Wolf, J. Fischer, W. Oster, P. Drings, K. Havemann
Blut 1990;61(2/3):74 A14
the german and the austrian Society of Hematology and Oncology, in Cologn, Sept.30-October3, 1990
 
4. Modulation of function of granulocytes by human GM-CSF and possible complications of GM-CSF therapy
M. Klausmann, K.H. Pflüger, D. Krumwieh, K. Havemann
Presented at the XIIIth Symposium of the International Association for Comparative Research on Leukemia and related diseases. Jerusalem 1987
Leukemia 1988;2(12):63S-72S
 
5. Stimulation des oxidativen Stoffwechsels von Granulozyten durch rH.GM-CSF und konditioniertes Medium der Blasenkarzinomzellinie 5637.
M. Klausmann, K.H. Pflüger, F.R. Seiler, K. Havemann
Klin. Wochenschr. 1987;65:190
( 93. Tagung der Deutsche Gesellschaft für Innere Medizin, Wiesbaden 1987)
 

Posterdemonstrationen (Als Abstract publiziert)
 
1. Développement des progéniteurs granulomonocytaires humains en gel de collagène: analyse des résultats et comparaison avec l´agar.
V. Praloran, M. Prigent, R. Garand, M.F. Naud, N. Milpied, J.L. Harousseau
Poster: Réunion du groupe prolifération et différentiation cellulaire, Société francaise d´hématologie, Bruxelles, Sept. 1985
Nouv. Rev. Franc. Hematol. 1985; 27:340a
 
2. Révélation des CFU-GM résiduelles après chimiothérapie in vitro: interet du gel de collagène et comparaison avec l´agar.
Poster: Réunion du groupe prolifération et differentiation cellulaire, Société francaise d´ hématologie, Bruxelles, Sept. 1985
Nouv. Rev. Franc. Hematol. 1985;27:
 
3. Autocrine growth factors in conditioned media of permanent cultures of acute myelomonocytic leukemia.
K.H. Pflüger, A. Grüber, H. Koeppler, M. Klausmann, K. Havemann
Poster DÖGHO 1987; Würzburg
Blut 1987;55(4):291 A169
 
4. Action of recombinant human GM-CSF on granulocyte functions.
M. Klausmann, M. Häder, K.H. Pflüger, D. Krumwieh, K. Havemann
Poster DÖGHO 1987; Würzbug
Blut 1987;55(4):218 A24
 
5. Effect of rH.GM-CSF on hematopoietic reconstitution after high dose chemotherapy in patients with small cell lung cancer.
M. Klausmann, M. Wolf, G. Fischer, P. Drings, K. Havemann
Poster ECCO 5 , London 1989. Abstract
 
6. rH.GM-CSF allows treatment intensification in patients with small cell lung cancer.
M. Klausmann, M. Wolf, J. Fischer, W. Oster, P. Drings, K. Havemann
Poster UICC; Hamburg 1990
 
7. Phase I/II trial of recombinant human interleukin-3 in patients with aplastic anemia.
A. Ganser, A. Lindemann, O.G. Ottmann, G. Seipelt, M. Eder, P. Meusers, M. Klausmann, F. Hermann, G. Schulz, R. Mertelsmann, D. Hoelzer.
Blut 1990;61(2/3):74 A13
 
8. Effects of different hematopoietic growth factors (IL-3, GM-CSF, G-CSF) on the in vitro growth of human leukemia and tumor cells.
M. Klausmann, M. Wolf, H. Köppler, K.H. Pflüger, C. Erbil, K. Havemann
Poster DÖGHO
Onkologie 1991; 14(2):84.Abstract 243
 
9. High-dose Ara-C, Cyclophosphamide and VP16 with autologous bone marrow transplantation for acute myeloid leukemia in first remission.
H. Koeppler, M. Klausmann, J. Heymanns, K.H. Pflüger, K. Havemann
Poster : Jahrestagung der DGHO und ÖGHO, Innsbruck 1991
Onkologie 1991;14(2): 88. Abstract 256
 
10. GM-CSF versus G-CSF in the treatment of infectious complications in Felty´s Syndrome. A case report.
U. Kaiser, M. Klausmann, G. Kolb, K.H. Pflüger
Poster: Jahrestagung der DGHO und ÖGHO, Innsbruck 1991
Onkologie 1991;14(2): 77. Abstract 222
 
11. Enhanced cytotoxicity through concomittant application of GM-CSF and chemotherapy.
M. Klausmann, M. Wolf, J.R. Fischer, W. Oster, P. Drings, K. Havemann
EJC 1991; 27(2): 234. Abstract 1433
Poster ECCO 6, Firenze, Italy 1991
 
12. Influence of GM-CSF schedule on post-chemotherapy myelosuppression
M. Klausmann, M. Wolf, J.R. Fischer, W. Oster, P. Drings, K. Havemann
Lung Cancer 1991;7S:141. Abstract 528
Poster: 6th world conference on lung cancer, Melbourne, Australia 1991
 
13. AIDS and Burkitt lymphoma of the appendix
M. Klausmann, K.H. Pflüger, M. Wolf, K. Havemann
Abstract 249.DÖGHO Essen , Germany,1993
 
14. Long term therapy with G-CSF low-dose in Felty´s Syndrome.
M. Klausmann, U. Kaiser, K.H. Pflüger, K. Havemann
Abstract 248. DÖGHO Essen, Germany, 1993
 
15.Deep vein thrombosis, dicoumarol necrosis of the left mamma in a woman with partially F. XII deficiency
U. Koehler, W.B. Schwerk, K. Görg, R. Seitz, M. Klausmann, R. Egbring, P. v. Wichert
Ann Hematol 1994: 68 (SII); A 309
 
16. Successful therapy and prevention of infections in Felty syndrome with long-term low dose G-CSF.
M. Klausmann, U. Kaiser, K.H. Pflüger, K. Havemann
Poster
J Cancer Res Clin Oncol 1994;120 (S): R 110
 
17. Deltastorage pool deficiency associated wiht thrombopenia and giant platelets.
M. Klausmann, C. Opper, J. Heymanns, M. Klump, R. Seitz, H. Kuni, H. Kern, K. Havemann
Br J Haem 1994; 87 (S1): A 962
 
18. A combination of vitamin D and A analogues induces growth inhibition of AML cell lines.
R. Jäger, P.M. Aries, M. Klausmann, K. H. Pflüger, K. Havemann
Onkologie 1994; 17 (S2): A 268
 
19. Deltastorage pool deficiency associated with thrombopenia and giant platelets.
M. Klausmann, C. Opper, J. Heymanns, M. Klump, R. Seitz, K. Havemann
Onkologie 1994; 17 (S2): A 302
 
20. Neopterin as an immunological activation marker in myelodysplastic syndromes.
M. Klausmann, T. Müller, K. Havemann
Onkologie 1995;18(S2):A 518
 

Nicht publizierte Vorträge
 
1. Action of rH. GM-CSF on granulocytes
M. Klausmann, K.H. Pflüger, D. Krumwieh, F.R. Seiler, K. Havemann
European School of Oncology (ESO), Venedig 1987
 
2. Granulocyte-macrophage colony-stimulating factor binding sites and oxidative metabolism in human granulocytes.
M.Häder, M. Klausmann, K.H. Pflüger, G. Lüben, F.R. Seiler, K. Havemann
Vortrag in Nantes
 
3. GM-CSF in der Therapie des kleinzelligen Bronchialkarzinoms
M. Klausmann
3e Wissentschaftliche Konferenz „Lungentumoren: Diagnostik, Therapie, Nachsorge”
Erfurt 1990